ATE283915T1 - Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation - Google Patents

Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation

Info

Publication number
ATE283915T1
ATE283915T1 AT99923766T AT99923766T ATE283915T1 AT E283915 T1 ATE283915 T1 AT E283915T1 AT 99923766 T AT99923766 T AT 99923766T AT 99923766 T AT99923766 T AT 99923766T AT E283915 T1 ATE283915 T1 AT E283915T1
Authority
AT
Austria
Prior art keywords
polypeptide
creb
polypeptides
protein
transcriptional regulation
Prior art date
Application number
AT99923766T
Other languages
English (en)
Inventor
Mark James O'connor
Holger Zimmermann
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9811303.8A external-priority patent/GB9811303D0/en
Priority claimed from GBGB9900157.0A external-priority patent/GB9900157D0/en
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Application granted granted Critical
Publication of ATE283915T1 publication Critical patent/ATE283915T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT99923766T 1998-05-26 1999-05-26 Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation ATE283915T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9811303.8A GB9811303D0 (en) 1998-05-26 1998-05-26 Polypeptides for use in transcriptional regulation
GBGB9900157.0A GB9900157D0 (en) 1999-01-05 1999-01-05 Polypeptides for use in transcriptional regulation
PCT/GB1999/001668 WO1999061608A2 (en) 1998-05-26 1999-05-26 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation

Publications (1)

Publication Number Publication Date
ATE283915T1 true ATE283915T1 (de) 2004-12-15

Family

ID=26313746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923766T ATE283915T1 (de) 1998-05-26 1999-05-26 Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation

Country Status (7)

Country Link
US (1) US6864054B1 (de)
EP (1) EP1082422B1 (de)
JP (1) JP2002516096A (de)
AT (1) ATE283915T1 (de)
AU (1) AU4052399A (de)
DE (1) DE69922372T2 (de)
WO (1) WO1999061608A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103508D0 (en) * 2001-02-13 2001-03-28 Univ Dundee Screening method and agents
JP6219849B2 (ja) 2012-01-24 2017-10-25 サンフォード ヘルス 発癌性ウイルスポリペプチド陽性腫瘍治療用ポリヌクレオチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2866695A (en) * 1994-07-08 1996-02-09 New England Medical Center Hospitals, Inc., The E6 binding proteins
AU7127296A (en) * 1995-09-18 1997-04-09 Novartis Ag Assay for identifying inhibitors of the interaction between proteins p53 and dm2
EP0958305B1 (de) * 1996-07-05 2008-06-04 Cancer Research Technology Limited Hemmer der interaktion zwischen p53 und mdm2
AU4043897A (en) * 1996-07-23 1998-02-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The P300/cbp-associated transcriptional co-factor p/caf and uses thereof

Also Published As

Publication number Publication date
EP1082422A2 (de) 2001-03-14
US6864054B1 (en) 2005-03-08
DE69922372T2 (de) 2005-12-15
WO1999061608A3 (en) 2000-03-30
AU4052399A (en) 1999-12-13
DE69922372D1 (de) 2005-01-05
JP2002516096A (ja) 2002-06-04
EP1082422B1 (de) 2004-12-01
WO1999061608A2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
DE69708737D1 (de) Überzugzusammensetzung, Druckmedium und Bildherstellungsverfahren unter Verwendung desselben
ITRE970057A0 (it) Procedimento di pressatura di polveri ceramiche ed attrezzatura di att uazione dello stesso.
DE69708214D1 (de) Sensorsystem zum prüfen der Eigenschaften von Papier
WO1991001621A3 (en) Composites and methods for making same
DE69722293D1 (de) Element zur Abtrennung von Wasserstoff
DE69424019D1 (de) System zur Sprachlichen Wiedergabe von Hypertextdokumenten, wie Hilfsdateien
AU4205299A (en) Method and apparatus for determining preexisting stresses based on indentation or other mechanical probing of the material
EE04424B1 (et) Peenpulbri transportimise meetod ja seade
DE69023120D1 (de) Infusionssystem, methodologie und algorithmus zur identifizierung von patienten-induzierten druckartefakten.
DE69836950D1 (de) Verbundmaterial auf basis von hexacyanoferraten und polymer , dessen herstellungsverfahren und verwendung
HK1040745A1 (zh) 胞質磷脂酶a2的晶體結構以及用其來鑒定激動劑和拮抗劑的方法
EP0967015A3 (de) Verwendung von Ferrocenylliganden zur katalytischen enantioselektiven Hydrierung
FI956049A7 (fi) Menetelmä jauhavien ja/tai dispergoivien aineiden valmistamiseksi fysikaalis-kemiallisella erotuksella, saadut aineet sekä niiden käytöt
DE69723067D1 (de) Taktiler sensor und dessen verwendung zur messung von scherkraft und schlupf
ID22091A (id) Metoda dan aparatus untuk penyaringan bubur dari kertas bekas
DE68913766D1 (de) Verwendung von nichtfarbigen lösungen zur desoxidation von aluminiumlegierungen.
DE69922372D1 (de) Polypeptide aus dem creb-bindenden protein und verwandten protein p-300 zur verwendung bei der transkriptionellen regulation
DE69218260D1 (de) KERAMISCHES VERBUNDMATERIAL, INSBESONDERE ZUR VERWENDUNG BEI TEMPERATUREN ÜBER 1400 o C
ATE253566T1 (de) Eine referenzverbindung zur verwendung in der analyse von levosimendan-chargen
ATE256657T1 (de) 2,5-substituierte benzolsulfonylharnstoffe und - thioharnstoffe, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmzeutische präparate
EP0954320A4 (de) Derivate von inositolpolyphosphat und methoden zu deren verwendung
DE69735015D1 (de) Neue Creatin-amidinohydrolase, ihre Herstellung und Verwendung
AU4375599A (en) Composite blade, capable of being used in different technical or industrial fields, in particular in the paper industry and printing
DE3576856D1 (de) Schutzloesung fuer stabilisierte vogelerythrozyten zur verwendung bei der virushaemagglutinierungsprobe.
AU4619297A (en) Ptx sensitive g proteins, the production and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties